Technology offers direct replacement for diesel systems and can be retrofitted into existing trailers
Reflect Scientific, Inc., a provider of products and services for the biotechnology, pharmaceutical and transportation industries, has been testing an electric-powered heavy-duty truck to potentially replace the diesel-powered tractor trailers that currently are in use for the movement of goods requiring controlled temperatures.
Cryometrix 53-foot reefer trailer (Credit: Reflect Scientific, Inc. via GlobeNewswire)
The Cryometrix CB-40 TRU is a pollution-free refrigeration alternative to diesel-powered systems, according to the company, which added that system weight is comparable to diesel units and can be retrofitted into existing trailers. The CB-40 uses a patented self-contained liquid nitrogen cooling system to achieve consistent temperature control with few moving parts.
The new 53-foot reefer trailer offers a temperature setpoint control that can be adjusted to match payload requirements that potentially could be used for shipping of biologics such as upcoming Covid-19 vaccines.
Demonstration runs conducted from Salt Lake City to Los Angeles and Denver reportedly were successful with the 525-mile Denver run going through varied outside air temperatures and multiple stops for unloading while maintaining internal temperature at -15°F.
Reflect Scientific, based in Orem, Utah, develops and markets proprietary technologies in cryogenic cooling for the biotechnology, pharmaceutical, medical and transportation markets.
Understanding the FDA's Exemption for DSCSA Compliance
November 12th 2024In the quest for achieving full traceability, the exemption applies to certain trading partners under the Act, and postpones enforcement of final compliance requirements while acknowledging progress and ongoing challenges.
Is Compounding the Answer to the Semaglutide Shortage? Experts Weigh In
October 30th 2024In this Q&A, Scott Brunner, CEO, and Tenille Davis, Chief Advocacy Officer, of the Alliance for Pharmacy Compounding discuss the challenges faced by patients and healthcare providers due to drug shortages, particularly for semaglutide and other medications.